Tax-efficient investments
Helping investors with their tax planning requirements
Innovative Investing
Growth capital specialists in the technology, life sciences and renewable energy sectors
Latest News
Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news
Our Products
An opportunity to participate in a range of diverse portfolios, proactively managed by our sector experienced team. Tax advantages are potentially available via the Enterprise Investment Scheme and Seed Enterprise Investment Scheme. Please view our specific product pages for more information. Financial Advice is recommended.
An opportunity for investors to participate in a portfolio of seed-stage technology innovation companies, whilst taking advantage of the potential tax benefits available under the Seed Enterprise Investment Scheme.
An opportunity for investors participate in a portfolio of growth-focused technology companies, whilst taking advantage of the potential tax benefits available under the Enterprise Investment Scheme.
An opportunity for investors to participate in a portfolio of growth-focused healthcare innovation companies, whilst taking advantage of the potential tax benefits available under the Enterprise Investment Scheme.
An asset-backed opportunity for investors to target long-term capital growth by investing in renewable energy generating trading assets.
The Private Investor Network of Deepbridge Capital, enabling experienced investors to define their own portfolio of innovative Life Sciences and Technology companies.
Deepbridge Protect is an IHT mitigation service that seeks to help businesses obtain full IHT relief, through their membership of a trading Partnership participating in a qualifying trade, so as to qualify for Business Relief.
Why you should invest with Deepbridge
Deepbridge Capital aims to redefine the growth capital market by providing you with access to opportunities which are sourced, reviewed and managed by our team of sector specialists.
Supporting energetic, passionate and knowledgeable management teams, Deepbridge seeks to identify highly innovative companies to grow into highly successful companies, with a view to providing optimal returns to our investors.
As an investment specialist in the technology, life sciences and renewable energy sectors, we work with investee companies throughout their funding journey with an eye on always producing a suitable exit for our investors.
Typically monthly deployments
Sector-experienced team
Thorough due-diligence process
Hands-on and active approach
100% Tax Efficiency for Investors
No management charges are levied on the investor at the point of investment for advised subscriptions received by a financial adviser, resulting in up to 100% allocation of subscription. This ensures up to 100% tax efficiency for investors. Deepbridge Capital fees are paid by Investee Companies and are disclosed in the Information Memorandum.
Testimonials
"Our partnership with Deepbridge has been invaluable in growing our business. Their active and hands-on approach was exactly what we were looking for when searching for a
Kam Pooni (CEO) Glyconics
funding partner, we wanted someone that not only understood our vision, but could also apply their experience to add real value to our organisation and that’s exactly what they have done. I look forward to working with them over the coming years, as we aim to provide investors with an optimum return on investment."
"Deepbridge Capital has been a critical partner in establishing Hurricane as the market leader in cross border eCommerce supply chain data provision. Deepbridge’s ability to generate the necessary financing to develop our innovative solutions, combined with the abundance of highly gifted personnel throughout their team to help guide our business, has been truly outstanding."
Martyn Noble (CHAIRMAN & CEO) Hurricane Modular Commerce
"Deepbridge has been a steadfast supporter of Chainvine. Having them as our principal investor has helped Chainvine open doors to clients and other funds that otherwise would have remained closed to a technology start-up."
Oliver Oram (CEO) Chainvine
"It was extremely important for Elasmogen that we worked with the right funding partners. Deepbridge's Life Sciences team understands our company and our sector, with their support therefore being invaluable and
Caroline Barelle, Elasmogen Limited (CEO)
much appreciated.
"
Latest News
The Adviser Evolution
The past decade has reshaped the UK’s financial advice profession more profoundly than any period since the introduction of RDR. Consolidation has…
Full article
CIO Update April 2026
If the last year has taught markets anything, it is that confidence can be a crowded trade. After a long stretch where returns were carried by a…
Full article
Why renewables are becoming central to tax-efficient planning
Renewable energy has reached an inflection point in the UK. What was once viewed as a specialist or thematic allocation is now central to the country…
Full articleEvents
EIS Portfolio Update – A Webinar Series 2026
17th June 2026
Our monthly briefing will provide a clear view of the latest developments across Deepbridge's EIS portfolios. We'll review portfolio highlights and…
Event Details
FlexEIS: Rethinking EIS for Year-Round Planning
23rd June 2026
Join our Sales Director, Steven Powell, on Tuesday, June 23rd, at 9:30am, as he discusses how FlexEIS transforms traditional EIS investing into a…
Event Details
